IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

Search

STRATEC Biomedical AG

Cerrado

16.72 -5.54

Resumen

Variación precio

24h

Actual

Mínimo

16.5

Máximo

17.7

Métricas clave

By Trading Economics

Ingresos

-5.8M

-4.3M

Ventas

18M

75M

P/B

Media del Sector

14.63

26.79

BPA

-0.357

Margen de beneficios

-5.772

Empleados

1,343

EBITDA

2.9M

11M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+67.05% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-12M

214M

Apertura anterior

22.26

Cierre anterior

16.72

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

STRATEC Biomedical AG Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 jul 2025, 17:24 UTC

Charlas de Mercado

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Comparación entre iguales

Cambio de precio

STRATEC Biomedical AG previsión

Precio Objetivo

By TipRanks

67.05% repunte

Estimación a 12 Meses

Media 29 EUR  67.05%

Máximo 37 EUR

Mínimo 21 EUR

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para STRATEC Biomedical AG Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 24.5Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

No Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
help-icon Live chat